The 24 hour variation of salivary carbamazepine and carbamazepine-10,11-epoxide concentrations in children with epilepsy
- 31 December 1987
- journal article
- Published by Elsevier in Pediatric Neurology
- Vol. 3 (6) , 327-330
- https://doi.org/10.1016/0887-8994(87)90002-6
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- A STUDY ON CARBAMAZEPINE LEVELS, INCLUDING ESTIMATION OF 10–11 EPOXY‐CARBAMAZEPINE AND LEVELS IN FREE PLASMA AND SALIVADevelopmental Medicine and Child Neurology, 1986
- Clinical Pharmacokinetics and Pharmacological Effects of Carbamazepine and Carbamazepine-10,11-EpoxideClinical Pharmacokinetics, 1986
- Fallacious Results from Measuring Salivary Carbamazepine ConcentrationsTherapeutic Drug Monitoring, 1985
- Carbamazepine 10,11-epoxide in children.British Journal of Clinical Pharmacology, 1984
- Concentrations and kinetics of carbamazepine in whole saliva, parotid saliva, serum ultrafiltrate, and serumClinical Pharmacology & Therapeutics, 1980
- Bioavailability of Four Different Pharmaceutical Preparations of CarbamazepineActa Pharmacologica et Toxicologica, 1978
- Kinetics of carbamazepine and carbamazepine‐epoxide, determined by use of plasma and salivaClinical Pharmacology & Therapeutics, 1978
- Salivary levels of anticonvulsantsNeurology, 1977
- Determination of carbamazepine and its epoxide metabolite in plasma by high-speed liquid chromatographyJournal of Chromatography A, 1975